Related Experiment Video
Updated: Jun 2, 2026

Screening People on Standing Balance with Romberg Testing and Walking Balance with Tandem Walking
Published on: September 1, 2023
Imipramine for vestibular dysfunction in panic disorder: a prospective case series.
Marco Andre Mezzasalma1, Kátia de Vasconcellos Mathias, Isabella Nascimento
1Panic and Respiration Laboratory, Psychiatric Institute, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil. mmezza@uol.com.br
Imipramine treatment significantly reduced anxiety and dizziness symptoms in patients with comorbid panic disorder and chronic dizziness. This 3-month course improved patients' quality of life.
Area of Science:
- Neurology
- Psychiatry
- Otolaryngology
Background:
- Comorbid chronic dizziness and panic disorder significantly impact quality of life.
- Effective treatment strategies for this comorbidity are limited.
Purpose of the Study:
- To evaluate the efficacy and effectiveness of imipramine in treating patients with comorbid chronic dizziness and panic disorder.
Main Methods:
- Nine patients with panic disorder and agoraphobia associated with chronic dizziness received a 3-month course of imipramine.
- Anxiety, dizziness, and panic severity were assessed using standardized scales (HAM-A, DHI, CGI).
Main Results:
- Imipramine treatment led to significant reductions in Hamilton Anxiety Scale (HAM-A) scores (p=0.008).
- Dizziness Handicap Inventory (DHI) scores also significantly decreased (p=0.008), indicating reduced dizziness impact.
- Clinical Global Impression (CGI) scores showed significant improvement (p=0.011).
Conclusions:
- Imipramine is effective in reducing anxiety levels in patients with comorbid chronic dizziness and panic disorder.
- A 3-month imipramine treatment course improves the quality of life by decreasing the impact of dizziness.
Related Concept Videos
Equilibrium and Balance
Panic Disorder
Anxiolytic Drugs: Benzodiazepines and Buspirone
The Vestibular System
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Generalized Anxiety Disorder
